The literature section is continuously being updated. An attempt is made to provide as comprehensive list of literature relating to the opsoclonus myoclonus syndrome as possible. Articles are superficially categorized for quick reference. Most, however, cover topics which cross over many areas relating to the syndrome. Medline data bases are periodically updated and URLs are subject to change without notice. Be sure that the article that you are attempting to link to is the one actually received. The Opsoclonus Myoclonus Support Network does not hold an opinion regarding the research presented nor its conclusions, if any. The literature list provided below is for reference and educational purposes only. If you are seeking medical advice, contact a physician.

REVIEW/SUMMARY TYPE ARTICLES

The neuropathology of paraneoplastic syndromes.Scaravilli F; An SF; Groves M; Thom MDepartment of Neuropathology, Institute of Neurology, The National Hospital Queen Square, London, UK. F.Scaravilli@ion.ucl.ac.uk Brain Pathol, 1999 Apr, 9:2, 251-60

Neurologic paraneoplastic syndromes.Dropcho EJ Department of Neurology, Indiana University Medical Center, Indianapolis 46202, USA. dropcho@iucc.iupui.edu J Neurol Sci,153(2):264-78 1998 Jan 8

[Kinsbourne syndrome: review of our cases] Rodrguez Barrionuevo AC; Caballero Morales MA; Delgado Marques MP; Mora Ramirez MD; Martinez AntonSecci de Neuropediatria, Hospital Materno-Infantil Carlos Haya, Espana ev Neurol R, 1998 Jun, 26:154, 956-9

Paraneoplastic ophthalmological syndromes. Constantinescu A Neurological Clinic, Rehabilitation Hospital, Iassy. Oftalmologia, 1996 Jul-Sep, 40:3, 214-8

Paraneoplastic nervous system syndromes. Jaeckle KA Department of Neuro-Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. Curr Opin Oncol, 1996 May, 8:3, 204-8

Neurological sequelae of the dancing eye syndrome. Pohl KR; Pritchard J; Wilson J Newcomen Centre, Guys Hospital, London, UK. Eur J Pediatr, 1996 Mar, 155:3, 237-44

Opsoclonus. Averbuch-Heller L; Remler B; Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA. Semin Neurol, 16(1):21-6 1996 Mar

The immunopharmacology of the opsoclonus-myoclonus syndrome. Pranzatelli MR; Department of Pediatrics, George Washington University, Washington, DC, USA. Clin Neuropharmacol, 19(1):1-47 1996 Feb

Paraneoplastic manifestations in children. de Graaf JH; Tamminga RY; Kamps WA Children's Cancer Centre, Beatrix Children's Hospital, University Hospital Groningen, The Netherlands. Eur J Pediatr, 153(11):784-91 1994 Nov

The neurobiology of the opsoclonus-myoclonus syndrome. Pranzatelli MR; Department of Neurology, George Washington University, Washington, DC. Clin Neuropharmacol, 15(3):186-228 1992 Jun

The remote effects of cancer on the nervous system. Dropcho EJ; Department of Neurology, Veterans Administration Medical Center, Birmingham, Alabama. Neurol Clin, 7(3):579-603 1989 Au

The opsoclonus-myoclonus syndrome. A review of the literature. Leder RM; Bull; Los Angeles Neurol Soc, 46():41-50 1981

Opsoclonus. Diagnosis and Discussion. author unknown; Digital Journal of Ophthalmology; MEEI Grand Rounds; date unavailable

ADULT RELATED TOPICS

Paraneoplastic opsoclonus-myoclonus syndrome and neurofibrosarcoma. Mitoma H; Orimo S; Sodeyama N; Tamaki M; Department of Neurology, Tokyo Medical and Dental University, Japan. Eur Neurol, 36(5):322 1996

The movement disorder of adult opsoclonus. Caviness JN; Forsyth PA; Layton DD; McPhee TJ; Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259. Mov Disord, 10(1):22-7 1995 Jan

Paraneoplastic opsoclonus-myoclonus syndrome in metastatic ovarian carcinoma ÍletterÍ Scholz J; Vieregge P; Ruff C. J Neurol Neurosurg Psychiatry, 57(6):763-4 1994 Jun

Novel brainstem syndrome associated with prostate carcinoma. Baloh RW; DeRossett SE; Cloughesy TF; Kuncl RW; Miller NR; Merrill J; Posner JB Department of Neurology, UCLA Medical Center.Neurology, 43(12):2591-6 1993 Dec

Paraneoplastic syndromes. Posner JB; Furneaux HM Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.Res Publ Assoc Res Nerv Ment Dis, 68():187-219 1990

Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Anderson NE; Budde-Steffen C; Rosenblum MK; Graus F; Ford D; Synek BJ; Posner JB; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021. Medicine (Baltimore), 67(2):100-9 1988 Mar

Opsoclonus in adults. Report of three cases and review of the literature. Digre KB Arch Neurol, 43(11):1165-75 1986 Nov

Paraneoplastic opsoclonus-myoclonus. Association with medullary thyroid carcinoma and review of the literature. Dropcho E; Payne R Arch Neurol, 43(4):410-5 1986 Apr

ANTIBODIES

[Paraneoplastic opsoclonus-myoclonus syndrome revealing T-cell lymphoma] Ducrocq X; Petit J; Taillandier L; Dorvaux V; Anxionnat R; Pl´enat F; Vespignani H Service de Neurologie, H^opital Central, Nancy. Presse Med, 28(7):330-3 1999 Feb 20

Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains. Lewis HA; Chen H; Edo C; Buckanovich RJ; Yang YY; Musunuru K; Zhong R; Darnell RB; Burley SK Laboratories of Molecular Biophysics, Howard Hughes Medical Institute, The Rockefeller University, 1230 York Avenue, New York, NY, 10021 USA. Structure, 7(2):191-203 1999 Feb 15

Anti-Ri positive opsoclonus-myoclonus-ataxia in ovarian duct cancer [letter] Jongen JL; Moll WJ; Sillevis Smitt PA; Vecht CJ; Tijssen CC J Neurol, 245(10):691-2 1998 Oct

Autoantibodies in childhood opsoclonus-myoclonus syndrome [editorial; comment] Posner JB; J Pediatr, 1997 Jun, 130:6, 855-7.

Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues [see comments] Connolly AM; Pestronk A; Mehta S; Pranzatelli MR 3rd; Noetzel MJ Department of Neurology, Washington University St. Louis Children's Hospital, Missouri 63110, USA. J Pediatr, 1997 Jun, 130:6, 878-84

The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Buckanovich RJ; Darnell RB Laboratory of Molecular Neuro-Oncology, The Rockefeller University, New York, New York 10021, USA. Mol Cell Biol, 1997 Jun, 17:6, 3194-201

Antineuronal antibody in a patient with neuroblastoma and opsoclonus-myoclonus-ataxia: a case report. Salmaggi A; Nemni R; Pozzi A; Silvani A; Forno MG; Luksch R; Confalonieri P; Boiardi A Instituto Nazionale Neurologico C. Besta, Milan, Italy. Tumori, 1997 May-Jun, 83:3, 709-11

Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis. Dropcho EJ Department of Neurology, Indiana University Medical Center, Indianapolis 46202-5111, USA. Ann Neurol, 39(5):659-67 1996 May

The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. Buckanovich RJ; Yang YY; Darnell RB Laboratory of Molecular Neuro-Oncology, Rockefeller University, New York, New York 10021, USA. J Neurosci, 1996 Feb 1, 16:3, 1114-22

Neurologic paraneoplastic syndromes and anti-neuronal antibodies Mygland A Nevrologisk avdeling, Vest-Agder Sentralsykehus, Kristiansand. Tidsskr Nor Laegeforen, 1996 Jan 30, 116:3, 361-5

ÍA case of opsoclonus-myoclonus syndrome associated with anti-central nervous system antibodyÍ Ushiyama M; Ishida K; Ikeda S; Imai H; Yanagisawa N Department of Neurology, Kenwakai Hospital. Rinsho Shinkeigaku, 34(9):898-902 1994 Sep

Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody Ísee commentsÍ Hersh B; Dalmau J; Dangond F; Gultekin S; Geller E; Wen PY; Division of Neurology, Brigham and Women's Hospital, Boston, MA 02115. Neurology, 44(9):1754-5 1994 Sep

Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome. Fisher PG; Wechsler DS; Singer HS; Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, Maryland. Pediatr Neurol, 10(4):309-12 1994 Jun

Antineuronal (anti-Ri) antibodies in a patient with steroid-responsive opsoclonus-myoclonus. Dropcho EJ; Kline LB; Riser J; Department of Neurology, University of Alabama, Birmingham. Neurology, 43(1):207-11 1993 Jan

An antineuronal autoantibody in paraneoplastic opsoclonus. Budde-Steffen C; Anderson NE; Rosenblum MK; Graus F; Ford D; Synek BJ; Wray SH; Posner JBDepartment of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021. Ann Neurol, 23(5):528-31 1988 May

Anti-neurofilament protein antibodies in opsoclonus-myoclonus. Noetzel MJ; Cawley LP; James VL; Minard BJ; Agrawal HC; J Neuroimmunol, 15(2):137-45 1987 Jun

BEHAVIORAL

Neurobehavioral and psychosocial functioning of children with opsoclonus-myoclonus syndrome. Papero PH; Pranzatelli MR; Margolis LJ; Tate E; Wilson LA; Glass P; Department of Psychiatry and Behavioral Sciences, Children's National Medical Center, George Washington University, Washington, DC 20010-2970, USA. Dev Med Child Neurol, 37(10):915-32 1995 Oct

Outcome of children with opsoclonus-myoclonus regardless of etiology. Hammer MS; Larsen MB; Stack CV; Division of Pediatric Neurology, Children's Memorial Hospital, Chicago, IL 60614, USA. Pediatr Neurol, 13(1):21-4 1995 Jul

Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma [see comments] Koh PS; Raffensperger JG; Berry S; Larsen MB; Johnstone HS; Chou P; Luck SR; Hammer M; Cohn SL; Northwestern University Medical School, Chicago, Illinois. J Pediatr, 125(5 Pt 1):712-6 1994 Nov

Behavioural disturbances after effective ACTH-treatment of the dancing-eyes syndrome [letter]Rutgers AW; Links TP; le Coultre R; Begeer JH Dev Med Child Neurol, 30(3):408-9 1988 Ju

DIAGNOSTIC METHODS

Opsoclonus-myoclonus syndrome with abnormal single photon emission computed tomography imaging. Oguro K; Kobayashi J; Aiba H; Hojo H Division of Child Neurology, Shizuoka Children's Hospital, Japan. Pediatr Neurol, 1997 May, 16:4, 334-6

Electrophysiological observations in idiopathic opsoclonus-myoclonus syndrome. Gwinn KA; Caviness JN Department of Neurology, Mayo Clinic Scottsdale, AZ 85259, USA. Mov Disord, 1997 May, 12:3, 438-42

[Neurologic signs and symptoms in viral infections--disease involving meninges, central nervous system or peripheral nerve system] Araga S; Nakashima K Division of Neurology, Faculty of Medicine, Tottori University. Nippon Rinsho, 1997 Apr, 55:4, 805-8

Correlation of clinical improvement with pontine lesions in opsoclonus-myoclonus syndrome. Tsutada T; Izumi T; Murakami T; Department of Geriatrics & Neurology, Osaka City University Medical School, Japan. Osaka City Med J, 42(1):53-60 1996 Jul

A sensitive and semi-quantitative pediatric myoclonus evaluation scale. Tate E; Prantelli MR; Ho H; Kim A Children's Research Institute, Washington, DC 20010, USA. J Neurosci Nurs, 1995 Oct, 27:5, 287-91

Paraneoplastic opsoclonus [letter; comment] Fisher PG; Singer HS Neurology, 1995 Jul, 45:7, 1421-2 Abstract unavailable online.

Immune diagnosis of paraneoplastic neurological disease. Moll JW; Vecht CJ Department of Neuro-Oncology and Neurology, Dr. Daniel den Hoed Cancer Center, Rotterdam, Netherlands. Clin Neurol Neurosurg, 1995 Feb, 97:1, 71-81

Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome. Pranzatelli MR; Huang Y; Tate E; Stanley M; Noetzel MJ; Gospe SM Jr; Banasiak K Department of Neurology, George Washington University, Washington, DC. Ann Neurol, 37(2):189-97 1995 Feb

Opsoclonus-myoclonus presenting with features of spasmus nutans. Allarakhia IN; Trobe JD; Department of Pediatrics (Pediatric Neurology), University of Michigan Medical Center, Ann Arbor, USA. J Child Neurol, 10(1):67-8 1995 Jan

Locating neuroblastoma in the opsoclonus-myoclonus syndrome. Shapiro B; Shulkin BL; Hutchinson RJ; Bass JC; Gross MD; Sisson JC; Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0028, USA. J Nucl Biol Med, 38(4):545-55 1994 Dec

Eye movements in children with opsoclonus-polymyoclonus. Shawkat FS; Harris CM; Wilson J; Taylor DS Department of Ophthalmology, Hospital for Sick Children, London, U.K. Neuropediatrics, 24(4):218-23 1993 Aug

Opsoclonus-myoclonus syndrome: an autopsy study of three cases. Young CA; MacKenzie JM; Chadwick DW; Williams IR Walton Centre for Neurology and Neurosurgery, Liverpool, United Kingdom. Eur J Med, 2(4):239-41 1993 Apr

Opsoclonus-myoclonus syndrome with abnormal magnetic resonance imaging and brainstem auditory evoked potentials. Araki K; Ueda Y; Hayafuji M; Takino T; Third Department of Internal Medicine, Kyoto Prefectural University of Medicine, Japan. Jpn J Med, 28(6):753-6 1989 Nov-Dec

Opsoclonus-myoclonus syndrome: correlation of radiographic and pathological observations. Tuchman RF; Alvarez LA; Kantrowitz AB; Moser FG; Llena J; Moshé SL Department of Neurology, Albert Einstein College of Medicine, Bronx, New York. Neuroradiology, 31(3):250-2 1989

Pontine lesion in opsoclonus-myoclonus syndrome shown by MRI. Hattori T; Hirayama K; Imai T; Yamada T; Kojima S; Department of Neurology, School of Medicine, Chiba University, Japan. J Neurol Neurosurg Psychiatry, 51(12):1572-5 1988 Dec

Dancing eyes syndrome--brainstem acoustic evoked potential approach. K´alm´anchey R; Veres E Department of Pediatrics, N. II of Semmelweis Medical School, Budapest, Hungary. Neuropediatrics, 19(4):193-6 1988 Nov

Neuropathologic findings in idiopathic opsoclonus and myoclonus. Their similarity to those in paraneoplastic cerebellar cortical degeneration. Hunter S; Kooistra C J Clin Neuroophthalmol, 6(4):236-41 1986 Dec

GENES

[Sibling cases of opsoclonus-polymyoclonus syndrome] Fujimoto Y; Isozaki E; Tanaka K; Kikuchi M; Hirai S Department of Neurology, Tokyo Metropolitan Neurological Hospital. Rinsho Shinkeigaku, 1997 Mar, 37:3, 261-3

Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus. Cohn SL; Salwen H; Herst CV; Maurer HS; Nieder ML; Morgan ER; Rosen ST; Division of Hematology/Oncology, Children's Memorial Hospital, Chicago, IL 60614. Cancer, 62(4):723-6 1988 Aug 15

NEUROBLASTOMA RELATED

Current aspects of biology, risk assessment, and treatment of neuroblastoma. Haase GM; Perez C; Atkinson JB Department of Pediatric Surgery, Children's Hospital, University of Colorado School of Medicine, Denver. GMHaase@aol.com Semin Surg Oncol, 1999 Mar, 16:2, 91-10

Neuroblastoma detected by somatostatin receptor scintigraphy in a case of opsoclonus-myoclonus-ataxia syndrome. Posada JC; Tardo C Children's Hospital, New Orleans, Louisiana, USA. J Child Neurol, 1998 Jul, 13:7, 345-6

[Hyperexcitability of the blink reflex in a child with opsoclonus-myoclonus syndrome] Maeoka Y; Maegaki Y DeDivision of Child Neurology, Tottori University Faculty of Medicine. No To Hattatsu, 30(4):323-7 1998 Jul

Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group. Russo C; Cohn SL; Petruzzi MJ; de Alarcon PA; Department of Pediatrics, Staford University, California, USA. Med Pediatr Oncol, 28(4):284-8 1997 Apr

Opsoclonus/myoclonus: paraneoplastic syndrome of neuroblastoma [clinical conference] Janss A; Sladky J; Chatten J; Johnson J; Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. Med Pediatr Oncol, 26(4):272-9 1996 Apr

Opsoclonus-myoclonus and recurrent neuroblastoma Íletter; commentÍ Basco WT Jr; Abboud M; Holden KR. J Pediatr, 126(5 Pt 1):847-8 1995 May

Opsoclonus-myoclonus, ataxia, and coincident neuroblastoma Íletter; commentÍ Chamberlain MC. J Pediatr, 126(4):675 1995 Apr

[Childhood dancing eye syndrome in occult neuroblastoma] K´alm´anchey R; Sallai A; Rudas G II. Gyermekklinika, Semmelweis, 133(35):2233-4, 2237 1992 Aug

Signs, symptoms, metastatic spread and metabolic behavior of neuroblastomas treated in Denmark during the period 1943-1980. Carlsen NL; Schroeder H; Christensen IJ; Bro PV; Hesselbjerg U; Jensen KB; Nielsen OH Anticancer Res, 7(3 Pt B):465-73 1987 May-Jun

Remote effects of neuroblastoma. Keating JW; Cromwell LD AJR Am J Roentgenol, 131(2):299-303 1978 Aug

POST VIRAL/OTHER RELATED CAUSES

Dancing eye syndrome and hyperphosphatasemia. Hasaerts DE; Gorus FK; De Meirleir LJ Department of Pediatrics, Academisch Ziekenhuis-Kinderen Vrije Universiteit Brussel, Brussels, Belgium. Pediatr Neurol, 18(5):432-4 1998 May

Spontaneous recovery of opsoclonus-myoclonus syndrome caused by enterovirus infection [letter] Tabarki B; Palmer P; Lebon P; Sébire G J Neurol Neurosurg Psychiatry, 1998 Mar, 64:3, 406-7

Opsoclonus-myoclonus associated with traditional medicine ingestion: case report. Adamolekun B; Hakim JG Department of Medicine, Faculty of Medicine, University of Zimbabwe, Avondale, Harare, Zimbabwe. East Afr Med J, 75(2):120-1 1998 Feb

[Hallucination in opsoclonus-polymyoclonus syndrome] Fujimoto Y; Isozaki E; Ootake T; Matsubara S; Hirai S Department of Neurology, Tokyo Metropolitan Neurological Hospital. Rinsho Shinkeigaku J, 37(9):806-9 1997 Sep

Neurologic signs and symptoms in viral infections--disease involving meninges, central nervous system or peripheral nerve system Araga S; Nakashima K Division of Neurology, Faculty of Medicine, Tottori University. Nippon Rinsho, 1997 Apr, 55:4, 805-8

Paraneoplastic opsoclonus associated with cancer of the gall bladder [letter] Corcia P; De Toffol B; Hommet C; Saudeau D; Autret A J Neurol Neurosurg Psychiatry, 62(3):293 1997 Mar

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 27-1995. A 29-month-old girl with worsening ataxia, nystagmus, and subsequent opsoclonus and myoclonus Íclinical conferenceÍ N Engl J Med, 333(9):579-86 1995 Aug 31

Opsoclonus myoclonus syndrome secondary to Epstein-Barr virus infection. Sheth RD; Horwitz SJ; Aronoff S; Gingold M; Bodensteiner JB; Department of Neurology, West Virginia University, Morgantown 26506-9180, USA. J Child Neurol, 10(4):297-9 1995 Jul

Paraneoplastic opsoclonus-myoclonus in Hodgkin's disease [letter] Kay CL; Davies-Jones GA; Singal R; Winfield DA J Neurol Neurosurg Psychiatry, 56(7):831-2 1993 Jul

Transient opsoclonus in organophosphate poisoning. De Bleecker JL Department of Neurology, University Hospital, Ghent, Belgium. Acta Neurol Scand, 86(5):529-31 1992 Nov

Myasthenia gravis in a child with sequelae of opsoclonus-myoclonus syndrome. Wilfong AA; Fernandez F Department of Pediatrics, Baylor College of Medicine, Houston, Texas. Can J Neurol Sci, 19(1):88-9 1992 Feb

Opsoclonus-myoclonus with Beckwith-Wiedemann syndrome and hepatoblastoma. Wilfong AA; Parke JT; McCrary JA 3d; Department of Pediatric Neurology, Baylor College of Medicine, Texas Children's Hospital, Houston 77030. Pediatr Neurol, 8(1):77-9 1992 Jan-Feb

A case of acute reversible opsoclonus-myoclonus syndrome [letter] Ganesh S; Kumar R; Dutta TK; Chandrasekar S J Assoc Physicians India, 39(2):226-7 1991 Feb. Abstract unavailable online.

Mumps-induced opsoclonus-myoclonus and ataxia. Ichiba N; Miyake Y; Sato K; Oda M; Kimoto H; Department of Pediatrics, Okayama University Medical School, Japan. Pediatr Neurol, 4(4):224-7 1988 Jul-Aug

Hearing loss as an initial symptom of the opsoclonus-myoclonus syndrome. Rosenberg NL; Arch Neurol, 41(9):998-9 1984 Sep

Myoclonic encephalopathy of infants or "dancing eyes syndrome . Report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma). Boltshauser E; Deonna T; Hirt HR Helv Paediatr Acta, 34(2):119-33 1979 May

[Syndrome of dancing eyes with myoclonic ataxia] Brune G; Hertel G; Gr¨uninger WKlin Monatsbl Augenheilkd, 158(1):41-8 1971 Jan

TREATMENTS

Immunoadsorption therapy for paraneoplastic syndromes. Batchelor TT; Platten M; Hochberg FH Stanford RE; Taff IP; Brain Tumor Center, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA. batchelor@helix.mgh.harvard.edu J Neurooncol, 1998 Nov, 40:2, 131-

Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma. Veneselli E; Conte M; Biancheri R; Acquaviva A; De Bernardi B Leigh RJDepartment of Pediatric Neuropsychiatry, University of Genoa, Italy.Med Pediatr Oncol, 30(1):15-7 1998 Jan

Medical treatments for abnormal eye movements: pharmacological, optical and immunological strategies. Averbuch-Heller L; Leigh RJ Department of Neurology, Veterans Affairs Medical Center, Cleveland, Ohio, USA.Aust N Z J Ophthalmol, 25(1):7-13 1997 Feb

Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin. Pless M; Ronthal M; Massachusetts Eye and Ear Infirmary, Boston, MA 02116, USA. Neurology, 46(2):583-4 1996 Feb

Treatment with intravenously administered immunoglobulins of the neuroblastoma-associated opsoclonus-myoclonus [letter] Borgna-Pignatti C; Balter R; Marradi P; Colamaria V J Pediatr, 1996 Jul, 129:1, 179-80 Abstract unavailable online

Immune globulin G for treatment of opsoclonus-polymyoclonus syndrome [letter] Eirís J; del Rió M; Castro-Gago M J Pediatr, 1996 Jul, 129:1, 175

Opsoclonus--myoclonus syndrome in an adult: a case report and response to clonazepam. Garg RK; Kar AM; Dixit V Department of Neurology, King George's Medical College, Lucknow. Indian J Ophthalmol, 1996 Jun, 44:2, 101-2. Abstract unavailable online.

Neuroblastoma-associated opsoclonus-myoclonus treated with intravenously administered immune globulin G. Petruzzi MJ; de Alarcon PA; Department of Pediatrics, Children's Hospital of Buffalo, NY 14222, USA. J Pediatr, 127(2):328-9 1995 Aug

Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption. Cher LM; Hochberg FH; Teruya J; Nitschke M; Valenzuela RF; Schmahmann JD; Herbert M; Rosas HD; Stowell C; Department of Neurology, Massachusetts General Hospital, Boston 02114, USA. Cancer, 75(7):1678-83 1995 Apr 1

Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome. Pranzatelli MR; Huang Y; Tate E; Stanley M; Noetzel MJ; Gospe SM Jr; Banasiak K Department of Neurology, George Washington University, Washington, DC. Ann Neurol, 37(2):189-97 1995 Feb

Improvement of paraneoplastic opsoclonus-myoclonus after protein A column therapy ÍletterÍ Nitschke M; Hochberg F; Dropcho E. N Engl J Med, 332(3):192 1995 Jan 19

Chlormethiazole in the management of the opsoclonus-myoclonus syndrome. Vilchez JJ; Lago A; Burguera JA; Yaya R; Casanova V; Department of Neurology, University Hospital La Fe, Valencia, Spain. J Int Med Res, 22(1):55-62 1994 Jan-Feb

On the molecular mechanism of adrenocorticotrophic hormone in the CNS: neurotransmitters and receptors Ísee commentsÍ Pranzatelli MR; Department of Neurology, George Washington University, Washington, DC 20010. Exp Neurol, 125(1):142-61 1994 Jan

Antibodies to ACTH in opsoclonus-myoclonus. Pranzatelli MR; Kao PC; Tate ED; Chaves E; Chez M; Dobyns WB; Kang H; Rothner DA; Department of Neurology, George Washington University, Washington, D.C. Neuropediatrics, 24(3):131-3 1993 Jun

---

This page hosted by Get your own Free Home Page